$IZEA
IZEA Worldwide, Inc.

2021 Q2 Form 10-Q Financial Statement

#000149523121000084 Filed on May 13, 2021

View on sec.gov

Income Statement

Concept 2021 Q2
Revenue $6.416M
YoY Change 110.39%
Cost Of Revenue $3.209M
YoY Change 132.89%
Gross Profit $3.208M
YoY Change 91.85%
Gross Profit Margin 49.99%
Selling, General & Admin $4.962M
YoY Change 57.58%
% of Gross Profit 154.7%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $363.9K
YoY Change -3.5%
% of Gross Profit 11.35%
Operating Expenses $4.962M
YoY Change 57.58%
Operating Profit -$2.119M
YoY Change 14.26%
Interest Expense $8.739K
YoY Change -55.13%
% of Operating Profit
Other Income/Expense, Net $1.960M
YoY Change 13552.35%
Pretax Income -$158.4K
YoY Change -91.15%
Income Tax
% Of Pretax Income
Net Earnings -$158.4K
YoY Change -91.39%
Net Earnings / Revenue -2.47%
Basic Earnings Per Share
Diluted Earnings Per Share -$2.581K
COMMON SHARES
Basic Shares Outstanding 61.73M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $74.99M
YoY Change 260.18%
Cash & Equivalents $74.99M
Short-Term Investments
Other Short-Term Assets $62.69K
YoY Change -52.02%
Inventory
Prepaid Expenses $1.027M
Receivables $6.133M
Other Receivables $0.00
Total Short-Term Assets $82.21M
YoY Change 237.3%
LONG-TERM ASSETS
Property, Plant & Equipment $193.8K
YoY Change -31.3%
Goodwill $4.017M
YoY Change 0.0%
Intangibles $72.22K
YoY Change -92.82%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $5.525M
YoY Change -18.27%
TOTAL ASSETS
Total Short-Term Assets $82.21M
Total Long-Term Assets $5.525M
Total Assets $87.74M
YoY Change 181.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.907M
YoY Change 47.77%
Accrued Expenses $2.097M
YoY Change 62.89%
Deferred Revenue $8.198M
YoY Change 48.78%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $31.31K
YoY Change -96.4%
Total Short-Term Liabilities $12.20M
YoY Change 36.7%
LONG-TERM LIABILITIES
Long-Term Debt $66.55K
YoY Change -94.26%
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $66.55K
YoY Change -94.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $12.20M
Total Long-Term Liabilities $66.55K
Total Liabilities $12.27M
YoY Change 21.61%
SHAREHOLDERS EQUITY
Retained Earnings -$72.54M
YoY Change 6.25%
Common Stock $6.181K
YoY Change 47.94%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $75.47M
YoY Change
Total Liabilities & Shareholders Equity $87.74M
YoY Change 181.81%

Cashflow Statement

Concept 2021 Q2
OPERATING ACTIVITIES
Net Income -$158.4K
YoY Change -91.39%
Depreciation, Depletion And Amortization $363.9K
YoY Change -3.5%
Cash From Operating Activities -$2.312M
YoY Change 298.57%
INVESTING ACTIVITIES
Capital Expenditures -$9.690K
YoY Change -80.62%
Acquisitions
YoY Change
Other Investing Activities -$1.080K
YoY Change -100.77%
Cash From Investing Activities -$10.77K
YoY Change -111.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 11.90M
YoY Change -24.09%
NET CHANGE
Cash From Operating Activities -2.312M
Cash From Investing Activities -10.77K
Cash From Financing Activities 11.90M
Net Change In Cash 9.580M
YoY Change -36.94%
FREE CASH FLOW
Cash From Operating Activities -$2.312M
Capital Expenditures -$9.690K
Free Cash Flow -$2.302M
YoY Change 334.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001495231
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61726599 shares
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59123449 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59123449 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50050167 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50050167 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59123449 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50050167 shares
CY2021Q1 izea Contractassetsandcontractliabilitieslengthofagreementwithcustomers
Contractassetsandcontractliabilitieslengthofagreementwithcustomers
P1Y
CY2021Q1 izea Lengthofcontractwithcustomers
Lengthofcontractwithcustomers
P1Y
CY2021Q1 izea Lengthofcontractwithcustomers
Lengthofcontractwithcustomers
P1Y
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-37703
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
IZEA WORLDWIDE, INC.
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
37-1530765
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
501 N. Orlando Avenue
CY2021Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 313
CY2021Q1 dei Entity Address Address Line3
EntityAddressAddressLine3
PMB 247
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Winter Park
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32789
CY2021Q1 dei City Area Code
CityAreaCode
407
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
674-6911
CY2021Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
CY2021Q1 dei Trading Symbol
TradingSymbol
IZEA
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
61726599 shares
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65465588 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
33045225 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4071940 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5207205 USD
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
380407 USD
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
199294 USD
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
48340 USD
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
74467 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
69966275 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
38526191 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
219563 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
230918 USD
CY2021Q1 us-gaap Goodwill
Goodwill
4016722 USD
CY2020Q4 us-gaap Goodwill
Goodwill
4016722 USD
CY2020Q4 us-gaap Goodwill
Goodwill
4016722 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
288889 USD
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
505556 USD
CY2021Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1356308 USD
CY2020Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1472684 USD
CY2021Q1 us-gaap Assets
Assets
75847757 USD
CY2020Q4 us-gaap Assets
Assets
44752071 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1675520 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1880144 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1680722 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1924973 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7222120 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7180264 USD
CY2021Q1 us-gaap Notes Payable Current
NotesPayableCurrent
1797976 USD
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
1477139 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
12376338 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
12462520 USD
CY2021Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
34292 USD
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
43808 USD
CY2021Q1 us-gaap Long Term Notes Payable
LongTermNotesPayable
138900 USD
CY2020Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
459383 USD
CY2021Q1 us-gaap Liabilities
Liabilities
12549530 USD
CY2020Q4 us-gaap Liabilities
Liabilities
12965711 USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
59123449 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
59123449 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50050167 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
50050167 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
5912 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
5005 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
135919529 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
102416131 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-72627214 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-70634776 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
63298227 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
31786360 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
75847757 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
44752071 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5375632 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4763668 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
2404752 USD
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
2140517 USD
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
2078323 USD
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1523143 USD
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2535147 USD
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2417838 USD
CY2021Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2020Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
4300000 USD
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
365529 USD
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
501269 USD
CY2021Q1 us-gaap Costs And Expenses
CostsAndExpenses
7383751 USD
CY2020Q1 us-gaap Costs And Expenses
CostsAndExpenses
10882767 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-2008119 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-6119099 USD
CY2021Q1 us-gaap Interest Expense
InterestExpense
13793 USD
CY2020Q1 us-gaap Interest Expense
InterestExpense
6618 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
29474 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-37744 USD
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
15681 USD
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-44362 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1992438 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-6163461 USD
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
56334219 shares
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34681198 shares
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
13718023 USD
CY2020Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
31250 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
2326 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
129571 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-6163461 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
7713057 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
31786360 USD
CY2021Q1 izea Stock Issued During Period Sale Of Securityvalue
StockIssuedDuringPeriodSaleOfSecurityvalue
34358012 USD
CY2021Q1 izea Stock Issued During Period Value Employee Purchase Price Plan And Stock Options Exercised
StockIssuedDuringPeriodValueEmployeePurchasePricePlanAndStockOptionsExercised
2144 USD
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
34696 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
746957 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
197986 USD
CY2021Q1 izea Share Based Payment Arrangement Value Shares Issued Net Of Tax Withholdings
ShareBasedPaymentArrangementValueSharesIssuedNetOfTaxWithholdings
-341576 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1992438 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
63298227 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1992438 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-6163461 USD
CY2021Q1 us-gaap Depreciation
Depreciation
32486 USD
CY2020Q1 us-gaap Depreciation
Depreciation
35629 USD
CY2021Q1 izea Amortizationofsoftwaredevelopmentcostsandotherintangibleassets
Amortizationofsoftwaredevelopmentcostsandotherintangibleassets
333043 USD
CY2020Q1 izea Payments To Proceeds From Developed Software
PaymentsToProceedsFromDevelopedSoftware
51004 USD
CY2020Q1 izea Amortizationofsoftwaredevelopmentcostsandotherintangibleassets
Amortizationofsoftwaredevelopmentcostsandotherintangibleassets
465640 USD
CY2021Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 USD
CY2020Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
4300000 USD
CY2021Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
7914 USD
CY2020Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2021Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2020Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
33305 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
197986 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
129571 USD
CY2021Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
34696 USD
CY2020Q1 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
31250 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1135265 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1585843 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
154986 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
15135 USD
CY2021Q1 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
0 USD
CY2020Q1 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
619 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-204624 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1121745 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-245077 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
215375 USD
CY2021Q1 izea Changeincontractwithcustomerliability
Changeincontractwithcustomerliability
41856 USD
CY2020Q1 izea Changeincontractwithcustomerliability
Changeincontractwithcustomerliability
-869287 USD
CY2021Q1 izea Change In Lease Liability
ChangeInLeaseLiability
0 USD
CY2020Q1 izea Change In Lease Liability
ChangeInLeaseLiability
24024 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-829707 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1348372 USD
CY2021Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
22109 USD
CY2020Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
0 USD
CY2021Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
8892 USD
CY2020Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2021Q1 izea Payments To Proceeds From Developed Software
PaymentsToProceedsFromDevelopedSoftware
0 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13217 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-51004 USD
CY2021Q1 izea Proceeds From The Sale Of Securities Financing Activities
ProceedsFromTheSaleOfSecuritiesFinancingActivities
34358012 USD
CY2020Q1 izea Proceeds From The Sale Of Securities Financing Activities
ProceedsFromTheSaleOfSecuritiesFinancingActivities
0 USD
CY2021Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
746957 USD
CY2020Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
2326 USD
CY2021Q1 izea Proceeds From Employee Stock Purchase Plan And Stock Options Exercised
ProceedsFromEmployeeStockPurchasePlanAndStockOptionsExercised
2144 USD
CY2020Q1 izea Proceeds From Employee Stock Purchase Plan And Stock Options Exercised
ProceedsFromEmployeeStockPurchasePlanAndStockOptionsExercised
0 USD
CY2021Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
341576 USD
CY2020Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2021Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
0 USD
CY2020Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
1162924 USD
CY2021Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
8336 USD
CY2020Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
11410 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
33263287 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1149188 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32420363 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-250188 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33045225 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5884629 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65465588 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5634441 USD
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
4792 USD
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
1368 USD
CY2021Q1 izea Equipmentacquiredwithfinancingarrangement
Equipmentacquiredwithfinancingarrangement
0 USD
CY2020Q1 izea Equipmentacquiredwithfinancingarrangement
Equipmentacquiredwithfinancingarrangement
43003 USD
CY2021Q1 izea Fairvalueofcommonstockissuedforfutureservices
Fairvalueofcommonstockissuedforfutureservices
147329 USD
CY2020Q1 izea Fairvalueofcommonstockissuedforfutureservices
Fairvalueofcommonstockissuedforfutureservices
125000 USD
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the </span></div><div style="margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which COVID-19 impacts the Company’s business and financial results will depend on numerous evolving factors including, but not limited to: the magnitude and duration of COVID-19, the extent to which it impacts worldwide macroeconomic conditions, the speed of the anticipated recovery, access to capital markets, and governmental and business reactions to the pandemic. The Company assessed certain accounting matters that generally require consideration of forecasted financial information in context with the information reasonably available to the Company and the unknown future impacts of COVID-19 as of March 31, 2021 and through the date of the filing of this Quarterly Report on Form 10-Q. The accounting matters assessed included, but were not limited to estimates related to revenue, the accounting for potential liabilities and accrued expenses, the assumptions utilized in valuing stock-based compensation issued for services, the realization of deferred tax assets, and assessments of impairment related to long-lived assets, intangible assets, and goodwill. The Company’s future assessment of the magnitude and duration of COVID-19, as well as other factors, could result in additional material impacts to the Company’s consolidated financial statements in future reporting periods.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the Company’s efforts, the ultimate impact of COVID-19 depends on factors beyond the Company’s knowledge or control, including the duration and severity of the outbreak, as well as third-party actions taken to contain its spread and mitigate its public health effects. As a result, the Company is unable to estimate the full extent to which COVID-19 will impact its financial results or liquidity. However, in consideration of the effect of COVID-19 on the assumptions and estimates used in the preparation of the financial statements, the Company identified the goodwill impairment disclosed in Note 3 as a material adverse effect on its results of operations and financial position in the first quarter of fiscal 2020 that was caused by COVID-19’s effect on economic conditions and its business operations.</span></div>
CY2021Q1 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 USD
CY2021Q1 us-gaap Cash Uninsured Amount
CashUninsuredAmount
62700000 USD
CY2020Q4 us-gaap Cash Uninsured Amount
CashUninsuredAmount
31400000 USD
CY2021Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
4019050 USD
CY2021Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
52890 USD
CY2020Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
5148213 USD
CY2020Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
58992 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
155000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
155000 USD
CY2021Q1 izea Bad Debt Expense Percentageof Revenues
BadDebtExpensePercentageofRevenues
0.01
CY2020Q1 izea Bad Debt Expense Percentageof Revenues
BadDebtExpensePercentageofRevenues
0.01
CY2021Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
Concentrations of credit risk with respect to accounts receivable have been typically limited because a large number of geographically diverse customers make up the Company’s customer base, thus spreading the trade credit risk. However, with the Company’s addition of SaaS customers, it has increased credit exposure on certain customers who carry significant credit balances related to their marketplace spend. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs credit evaluations of its customers, but generally does not require collateral to support accounts receivable. The Company had no customer that accounted for more than 10% of total accounts receivable at March 31, 2021 and December 31, 2020. The Company had no customer that accounted for more than 10% of its revenue during the three months ended March 31, 2021 and 2020.
CY2021Q1 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 USD
CY2020Q1 us-gaap Tangible Asset Impairment Charges
TangibleAssetImpairmentCharges
0 USD
CY2021Q1 us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 operating_units
CY2021Q1 izea Amortizationperiodofsoftwaredevelopmentcosts
Amortizationperiodofsoftwaredevelopmentcosts
P5Y
CY2021Q1 izea Leaseterm
Leaseterm
P12M
CY2021Q1 izea Leaseterm
Leaseterm
P12M
CY2021Q1 izea Invoicepaymentterms
Invoicepaymentterms
P30D
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
802124 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
802910 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
582561 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
571992 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
219563 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
230918 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6211469 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5922580 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6211469 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5705913 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6211469 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6211469 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5922580 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
5705913 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
288889 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Remaining Amortization Period1
FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1
P4M
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
505556 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
288889 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
288889 USD
CY2019Q4 us-gaap Goodwill
Goodwill
8316722 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
4300000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
4016722 USD
CY2021Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021Q1 us-gaap Goodwill
Goodwill
4016722 USD
CY2020Q1 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
4300000 USD
CY2021Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
3036810 USD
CY2021Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
131593 USD
CY2020Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
286455 USD
CY2021Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
31312 USD
CY2020Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
3036810 USD
CY2021Q1 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1680502 USD
CY2020Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
1564126 USD
CY2021Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1356308 USD
CY2020Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
1472684 USD
CY2021Q1 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
0 USD
CY2020Q1 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
51004 USD
CY2021Q1 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
3036810 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
6616 USD
CY2021Q1 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
1320452 USD
CY2020Q4 us-gaap Accrued Salaries Current And Noncurrent
AccruedSalariesCurrentAndNoncurrent
1504113 USD
CY2020Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1924973 USD
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
30487 USD
CY2021Q1 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
197365 USD
CY2020Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
103918 USD
CY2021Q1 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
1680722 USD
CY2021Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
52407 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
1498935 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
493125 USD
CY2021Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
10420 USD
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
2002480 USD
CY2021Q1 izea Number Of Operating Lease Liabilities
NumberOfOperatingLeaseLiabilities
1 lease
CY2020Q1 izea Number Of Operating Lease Liabilities
NumberOfOperatingLeaseLiabilities
1 lease
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q1 izea Numberofindependentdirectors
Numberofindependentdirectors
5 directors
CY2020Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
59051 USD
CY2021Q1 izea Percentageofindividualownershipofcommonstock
Percentageofindividualownershipofcommonstock
0.10
CY2021Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2144 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4651 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3277104 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-1992438 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-6163461 USD
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
56334219 shares
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
34681198 shares
CY2021Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.04
CY2020Q1 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-0.18
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2422394 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2571106 shares
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5375632 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4763668 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5375632 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4763668 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4071940 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5207205 USD
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7222120 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
7180264 USD
CY2021Q1 izea Contract Length For Sales Commissions Payment
ContractLengthForSalesCommissionsPayment
1

Files In Submission

Name View Source Status
0001495231-21-000084-index-headers.html Edgar Link pending
0001495231-21-000084-index.html Edgar Link pending
0001495231-21-000084.txt Edgar Link pending
0001495231-21-000084-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
izea-20210331.htm Edgar Link pending
izea-20210331.xsd Edgar Link pending
izea-20210331_cal.xml Edgar Link unprocessable
izea-20210331_def.xml Edgar Link unprocessable
izea-20210331_htm.xml Edgar Link completed
izea-20210331_lab.xml Edgar Link unprocessable
izea-20210331_pre.xml Edgar Link unprocessable
izea210331ex311.htm Edgar Link pending
izea210331ex312.htm Edgar Link pending
izea210331ex321.htm Edgar Link pending
izea210331ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending